Pfizer – Understanding Healthcare Disparities in IBD Patients in Underserved Communities – Request for Proposals

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within your unit

Memorial Deadline: Thursday 24th, June 2021

External Deadline: Tuesday 29th, June 2021


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Area of Interest – Inflammatory Bowel Disease.

Projects that will be considered for support will focus on understanding health care disparities among under represented populations in IBD with a special emphasis on healthcare resources access and utilization.

Examples include but are not limited to: Access to gastroenterologist-led care, access to appropriate therapies and testing, assessing appropriate steroid utilization, ER/Urgent Care use, and healthcare maintenance (such as vaccination, bone health, lab monitoring, cancer prevention, smoking cessation, behavioral health and/or nutritional assessment).

Projects which entail systematic and continuous actions able to demonstrate measurable outcomes via methodologically rigorous methods will be given the highest priority.

Priority will also be given to projects that address patients who are part of a medically underserved population; this is defined as patients who have experienced health and/or healthcare system disparities secondary to social determinants of health.

Key Dates:

  • * RFP release date: June 2nd, 2021
  • * Grant Application due date: June 29th, 2021 Please note the deadline is 23:59 Eastern Standard Time (e.g. New York, GMT -5).
  • * Anticipated Grant Award Notification Date: August, 2021
  • * Grants will be distributed following a fully executed agreement.
  • *Anticipated Project Start and End Dates: On or after September 1st, 2021 upon contract execution, for a duration of 1 year.

Additional information can be found here.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: June 7, 2021